High proportion of rare and compound epidermal growth factor receptor mutations in an <scp>A</scp>ustralian population of non‐squamous non‐small‐cell lung cancer

Abstract

The incidence of EGFR mutation may be higher in Australian populations than in other populations of predominantly European origin. Rare and compound EGFR mutations may occur and may have implications for treatment that differ from classically activating mutations.